Sanofi Consumer Healthcare India Ltd

  • BSE Code : 544250
  • NSE Symbol : SANOFICONR
  • ISIN : INE0UOS01011
  • Industry :PHARMACEUTICALS - MULTINATIONAL

up-arrow 4,474.10 -13.80(-0.31%)

Open Price ()

4,500.00

Prev. Close ()

4,487.90

Volume (No’s)

1,519

Market Cap ()

10,304.13

Low Price ()

4,450.10

High Price ()

4,500.00

 

Book Closure

From Date To Date Announcement
12-Nov-2025 NA Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended 30th September 2025 We wish to inform you that the Board of Directors at its meeting held today i.e., Wednesday, 12th November 2025, inter-alia considered and approved the Unaudited Financial Results for the quarter and nine months ended 30th September 2025. (As Per BSE Announcement Dated on: 12/11/2025)
29-Oct-2025 30-Oct-2025 Intimation of dispatch of Postal Ballot Notice to the Shareholders Please find enclosed Scrutinizer''s Report issued by M/s. MMJB & Associates LLP w.r.t. Postal Ballot Notice dated 4th August 2025 Please find enclosed Voting Results for the Postal Ballot Notice dated 4th August 2025 (As Per BSE Announcement Dated on:30.10.2025)
16-Oct-2025 NA Appointment of Mr. Richard D''souza as Chief Financial Officer of the Company w.e.f. 16th October 2025
15-Oct-2025 NA Resignation of Mr. Narahari Naidu as Chief Financial Officer of the Company
04-Aug-2025 NA Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th June 2025 We refer to our letter dated 29th July 2025 informing you of our Board Meeting that was scheduled today. In this regard, we wish to inform you that the Board of Directors at its meeting held today i.e. Monday, 4th August 2025, inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2025. Outcome of Board Meeting for consideration and approval of Unaudited Financial Results for the quarter and half year ended 30th June 2025 (As Per BSE Announcement Dated on :04.08.2025)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew